Full Prescribing
Information
Click here for information on:
Peripheral Nerve Blocks for Upper Body Surgery »
Peripheral Nerve Blocks for Lower Body Surgery
NAROPIN Delivers A Faster Return of Lower Body Motor Function
Reference: 1. Beaulieu P, Babin D, Hemmerling T. The pharmacodynamics of ropivacaine and bupivicaine in combined sciatic and femoral nerve blocks for total knee arthroplasty. Anesth Analg. 2006;103:768-774.
Peripheral Nerve Blocks for Upper Body Surgery
NAROPIN Delivers A Faster Return of Upper Body Motor Function
Reference: 1. McGlade DP, Kalpokas MV, Mooney PH, et al. A comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia. Anaesth Intensive Care. 1998;26:515-520.
Peripheral Nerve Blocks for Lower Body Surgery
NAROPIN Delivers A Faster Return of Lower Body Motor Function
Significantly Faster Return of Motor Function following Sciatic-Femoral Block for Total Knee Replacement1
In equal concentrations of 0.5%, NAROPIN patients experienced an 8-10 hours faster return of motor function following total knee arthroplasty.1
NAROPIN Maintains Effective Sensory Blockade
Overall, the quality of analgesia was similar between NAROPIN and bupivicaine.1
NAROPIN is indicated for the production of regional or local anesthesia for surgery and for acute pain management.
Reference: 1. Beaulieu P, Babin D, Hemmerling T. The pharmacodynamics of ropivacaine and bupivicaine in combined sciatic and femoral nerve blocks for total knee arthroplasty. Anesth Analg. 2006;103:768-774.
Peripheral Nerve Blocks for Upper Body Surgery
NAROPIN Delivers A Faster Return of Upper Body Motor Function
Significantly Faster Return of Motor Function Following Brachial Plexus Nerve Block for Wrist and Hand Surgery1
In equal concentrations of 0.5%, NAROPIN patients experienced a 5.6-9.6 hours faster return of motor function following lower arm surgery.1
NAROPIN Maintains Effective Sensory Blockade
Overall, the quality of analgesia was similar between NAROPIN and bupivicaine.1
NAROPIN is indicated for the production of regional or local anesthesia for surgery and for acute pain management.
Reference: 1. McGlade DP, Kalpokas MV, Mooney PH, et al. A comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia. Anaesth Intensive Care. 1998;26:515-520.
Important Safety Information
Using NAROPIN beyond recommended doses to increase motor block or duration of sensory block may negate its favorable cardiovascular advantages, in the event that an inadvertent intravascular injection occurs.
Like all amide-type local anesthetics, NAROPIN may be associated with adverse reactions. In clinical trials, side effects were mild and transient and may reflect the procedures, patient health status, and/or other medications used. Adverse events reported at a rate of ≥5%: hypotension, nausea, vomiting, bradycardia, fever, pain, postoperative complications, anemia, paresthesia, headache, pruritus, and back pain.
New Safety Information
There have been adverse event reports of chondrolysis in patients receiving intra-articular infusions of local anesthetics following arthroscopic and other surgical procedures. NAROPIN is not approved for this use.
®
Using NAROPIN beyond recommended doses to increase motor block or duration of sensory block may negate its favorable cardiovascular advantages, in the event that an inadvertent intravascular injection occurs.
Like all amide-type local anesthetics, NAROPIN may be associated with adverse reactions. In clinical trials, side effects were mild and transient and may reflect the procedures, patient health status, and/or other medications used. Adverse events reported at a rate of ≥5%: hypotension, nausea, vomiting, bradycardia, fever, pain, postoperative complications, anemia, paresthesia, headache, pruritus, and back pain.
New Safety Information
There have been adverse event reports of chondrolysis in patients receiving intra-articular infusions of local anesthetics following arthroscopic and other surgical procedures. NAROPIN is not approved for this use.
Please see Full Prescribing Information at www.naropin-us.com.
NAROPIN® and logo are registered trademarks of APP Pharmaceuticals, LLC.
®and APP® are registered trademarks of APP Pharmaceuticals, LLC.
©2010, APP Pharmaceuticals, LLC. All Rights Reserved.